Conferences

Home>News>Conferences

Cartherics to present at Australia Biologics 2023

Cartherics is pleased to announce that Dr Madeline Cao, Research Fellow, will be presenting at Australia Biologics 2023 at Crown Promenade, Melbourne.

The Australia Biologics Festival 2023 is Australia’s premier conference that aims to gather the innovators, pioneers, leaders in the biologics fraternity including biologics, biosimilars, vaccines, cell and gene therapy (CGT) and evolving therapeutics […]

2023-05-24T13:41:49+10:00February 28th, 2023|

Cartherics to Present at Biotech Showcase™ 2023

Cartherics to Present at Biotech Showcase™ 2023

Dr Ian Nisbet will provide a presentation on Cartherics’ technology and development program at Biotech Showcase, with a view to engaging with potential investors and partners

Melbourne, Australia, 22 December 2022Cartherics, a biotechnology company developing immune cell therapies for the treatment of cancer, announced today that it […]

2023-01-27T11:50:03+11:00December 22nd, 2022|

Presentation at the Locust Walk Stem Cell Tx Conference

Dr Ian Nisbet Chief Operating Officer

Held in partnership with Harvard Stem Cell Institute, this virtual one-day investor and partner conference will explore stem cell therapeutics in the areas of regenerative medicine, oncology and emerging academic research. It will also showcase cutting-edge science, industry trends and the commercial potential of this innovative sector to an invited […]

2022-04-08T11:41:15+10:00April 8th, 2022|

7th Innate Killer Summit 2022, Dr Nicholas Boyd Presenting

7th Innate Killer Summit (San Diego, California)

Cartherics Chief Development Officer, Dr Nicholas Boyd

The innate cell therapy field is exploding as novel research charges through the clinic, proving its potential as a safe, efficacious, and cost-effective treatment. From 30 March-1 April 2022 Pacific Daylight Time (PDT) industry experts will meet in San Diego, California to discuss […]

2022-11-09T17:13:54+11:00March 25th, 2022|

The 4th Allogeneic Cell Therapies Summit is the leading industry-dedicated meeting that considers pre-clinical developmenttranslationmanufacturingsupply and storage of allogeneic cell therapies to improve the accessibility and efficacy of patient care worldwide.

400+ experts from pharma, biotech and leading academia are expected to attend in Boston, USA […]

2022-03-04T14:28:58+11:00March 4th, 2022|

Presentation at the Next Generation CAR-TCR Summit (London, UK)

Presentation at the Next Generation CAR-TCR Summit (London, UK)

Cartherics Chief Development Officer, Dr Nicholas Boyd

CAR-T immunotherapy has exploded over the last half a decade. It is now a billion-dollar market that is expanding rapidly with over 400+ new cell therapy trials in 2021 alone. But challenges still remain in solid tumours, toxicity management and manufacturing […]

2022-03-08T18:59:41+11:00February 23rd, 2022|

Presentation: Multi-Functional Cell Therapies Summit

Chief Development Officer, Dr Nicholas Boyd

Cell therapies have the potential to not only be life-saving but curative for a host of diseases. However, inherent limitations in autologous based CAR-T therapy face major roadblocks for mass adoption and therapeutic effects in solid tumour indications.

On Friday 28 January at 7:30 am AEDT Nicholas will discuss the design, […]

2022-01-27T16:58:33+11:00January 27th, 2022|

WEHI Doctoral Student Wins Cartherics Award

Natalia Benetti’s winning presentation was a hit at virtual Victorian meeting

https://www.anzscdb.org/

By Leigh Dayton

27 August 2021

Cartherics CEO Alan Trounson congratulates Natalia Benetti for her important research in developmental cell biology: “It’s great work and very well presented”.

The company also applauds the Australian Regenerative Medicine Institute for successfully organising the 13th Victorian State Conference of the […]

2021-08-27T19:08:02+10:00August 27th, 2021|

Victorian development biologists are gathering in August & Cartherics joins the intellectual party

By Leigh Dayton

22 July 2021

Cartherics is delighted to announce that it is a sponsor of the Australia and New Zealand Society of Cell and Developmental Biology’s Victorian State Conference. The highly regarded one-day event is booked for 26 August at the University of Melbourne.

Cartherics CEO Alan Trounson welcomes the opportunity to support the meeting.

“It is […]

2021-07-22T12:58:44+10:00July 22nd, 2021|

‘Off-the-Shelf’ Immunotherapy for Ovarian Cancer

Cartherics’ CEO Alan Trounson speaks at the  BIO KOREA 2021 International Convention

By Leigh Dayton

11 June 2021

Alan Trounson joined a day-long discussion on advances in regenerative medicine. The virtual event brought together the world’s leading experts.

At the session on emerging immuno-oncology, Trounson told delegates that Cartherics believes its novel CAR-T and CAR-NK cells have great potential […]

2021-06-11T19:55:32+10:00June 11th, 2021|
Go to Top